Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    10954759 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The Estrogen Replacement and Atherosclerosis Trial ; Primary Outcome Measure is Mean Minimal Coronary Artery Diameter After Avg of 3.2 Yrs.
Condition: Heart Disease
Interventions: Drug: 0.625 mg of conjugated equine estrogen;   Drug: 0.625 mg of conjugated equine estrogen plus 2.5 mg of medroxyprogesterone acetate;   Drug: placebo tablets
2 Completed Estrogen, HDL, and Coronary Heart Disease in Women
Conditions: Cardiovascular Diseases;   Coronary Disease;   Heart Diseases;   Coronary Arteriosclerosis
Interventions: Drug: Estrogens, Conjugated (USP);   Drug: Medroxyprogesterone 17-Acetate;   Drug: Placebo
3 Completed Estrogen Replacement and Atherosclerosis (ERA) in Older Women
Conditions: Cardiovascular Diseases;   Coronary Arteriosclerosis;   Coronary Disease;   Heart Diseases;   Myocardial Ischemia;   Postmenopause
Interventions: Drug: estrogen replacement therapy;   Drug: hormone replacement therapy;   Drug: estrogens;   Drug: progestins

Study has passed its completion date and status has not been verified in more than two years.